ClinicalTrials.gg
RecruitingNCT06015451Updated Aug 11, 2026

Exercise in Postconcussion Symptoms and Posttraumatic Headache

An interventional study of Sub-symptom threshold exercise in Brain Concussion, Post-Concussion Syndrome and Post-Traumatic Headache, sponsored by St. Olavs Hospital. Recruiting at 1 site in Norway. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-11.

Primary conditionPost-Concussion SyndromeRegistry: Brain ConcussionReclassifiedWhy we changed it
Registry
Brain Concussion — the first condition term the registry derived for this study.
ClinicalTrials.gg
Post-Concussion Syndrome
Why
  1. The study's listed conditions name Post-Concussion Syndrome, a narrower term within Brain Concussion.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by St. Olavs Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Nov 2022, registered Jul 2023).
  • Started Nov 2022; still recruiting 4 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare two models of delivery of guided exercise in patients with exercise intolerance after mild head injury.

The main question it aims to answer is:

  • Is a program that includes elements of in-house exercise and follow-up sessions, and repeated treadmill testing, superior to a program with telephone-based follow-up only?

Participants will undergo a treadmill test to determine eligibility for the study, and to determine at what intensity level their symptoms worsen (symptom threshold). Thereafter they will exercise 15-20 minutes, 3-5 times per week at 80-90% of the heart rate that was found to be the symptom threshold. One group will receive face-to-face folllow-up and repeated testing, one group will receive telephone-based follow-up only .

Researchers will compare these two groups to see if closer follow-up is superior when it comes to recovery from exercise intolerance after 12 weeks of exercise.

Read the detailed description

Patients with self-reported symptom exacerbation in relation to physical activity will be screened for inclusion with Buffalo Concussion Treadmill test (BCTT), an incremental treadmill exercise test according to a standard Balke protocol, to the first sign of symptom exacerbation or submaximal exertion. Heart rate and perceived exertion (Borg scale) are measured every minute. Patients who demonstrate symptom exacerbation according to predefined criteria will receive an individually tailored program for workouts with self-selected aerobic activites, of 15-20 minutes duration, 4-5 times per week at 85-90% (measured with HR monitor) of the HR at test termination, and they are randomised to either:

A. Every week the first three weeks, participants will exercise one individual session at the hospital, and the BCTT will be performed every 3rd week at the hospital to be able to shape the intervention.

B. The participants will only exercise at home, and will be contacted by telephone/video call, every week during the first three weeks, thereafter less often, up to every third week.

After 12 weeks, there will be a repeated BCTT, performed by a blinded assessor.

Patient reported outcomes are collected using electronic questionnaires before and after the intervention and 6 months after inclusion.

02

Conditions studied

  • Brain Concussion
  • Post-Concussion Syndrome
  • Post-Traumatic Headache
  • Craniocerebral Trauma

Keywords

  • exercise intolerance
  • exercise
  • Thread mill test
03

In context

Post-Concussion Syndrome Reclassified

141 studies on the registry are indexed under Post-Concussion Syndrome; 34 are open to participants now.

This study's planned enrollment of 100 is above the median of 52 across 114 interventional studies indexed under Post-Concussion Syndrome.

Browse Post-Concussion Syndrome studies →

Lead sponsor

St. Olavs Hospital is the lead sponsor of 171 studies on the registry; 29 are open to participants now.

Compared within Post-Concussion Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Brain Concussion. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-65 years
  • Having sustained a minimal head injury or mild traumatic brain injury at least 2 weeks ago.
  • At least one postconcussion symptoms, of at least moderate degree, occurring within the first week after the head injury.
  • Intolerance for physical activity (self-reported and measured; including symptom exacerbation later on the test day).
  • Capable of giving .

Exclusion criteria

Exclusion Criteria:

  • More than 2 years since last injury.
  • The symptoms are better explained by other conditions.
  • Severe communication problems, typically due to poor knowledge of Norwegian.
  • Severe psychiatric, neurological, somatic, or substance abuse disorders that will make it problematic to function in a group and/or will complicate follow-up and outcome assessment.
  • Safety concerns according to the study medical checklist.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Follow-up face-to face

    Home-based and in-house exercise, supervised both by telephone and face-to-face. Every week the first three weeks participants will exercise one session at the hospital, and the BCTT/BCCT will be performed every 3rd week, at the hospital in order to be able to shape the intervention.

    Other: Sub-symptom threshold exercise

  • Active comparator
    Follow-up over the phone

    Home-based exercise only, supervised by telephone. The participants will exercise solely in the home setting and will be contacted by telephone, every week during the first three weeks, thereafter every third week. Based on the therapist's evaluation during these calls, the intervention is shaped.

    Other: Sub-symptom threshold exercise

Interventions

  • OtherSub-symptom threshold exercise

    Aerob exercise at an intensity just below the intensity that provokes symptom exacerbation.

06

What researchers measure

Primary outcomes

  1. Exercise tolerance

    Change in heart rate at test termination (the Buffalo Concussion Treadmill Test)

    Time frame: 3 months

Secondary outcomes

  1. Headache burden

    Change in days of headache of at least moderate intensity

    Time frame: 6 months

  2. Change on self-selected area of function.

    Change on the Patient-specific Function Scale (PSFS), the first 3 items, range 0-30, highest is worst.

    Time frame: 6 months

  3. Self-reported amount of physical activity

    Change on the International Physical Activity Questionnaire (IPAQ), higher total values indicate more physical activity.

    Time frame: 6 months

  4. Quality of life after head injury (QOL)

    Change on the Quality of life after brain injury - Overall Scale (QOLIBRI - OS). Six items rated on an ordinal scale, higher score indicate better QOL.

    Time frame: 6 months

  5. Depressive symptoms

    Change on the Patient Health Questionnaire (PHQ-9). Nine items range 0-3, higher score indicates more severe depressive symptoms.

    Time frame: 6 months

  6. Anxiety

    Change on the Generalized Anxiety Disorder Scale (GAD-7). Seven items range 0-3, higher score indicates more severe symptoms of anxiety.

    Time frame: 6 months

  7. Impact of headaches

    Change on the Headache Impact Test (HIT)-6. Six items, Total score ranges from 36-78, higher score indicates higher impact.

    Time frame: 6 months

  8. Fatigue

    Change on the Fatigue Severity Scale (FSS). Nina items, total score range 9-63, higher score indicates more severe fatigue.

    Time frame: 6 months

  9. Adherence to training

    The Problematic Experience of Therapy scale (PETS). 12 questions with responses on a Likert scale. No total score.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • St. Olavs Hospital, Clinic of Rehabilitation
    Trondheim, 7050, Norway
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2022 (actual). Primary completion is estimated for Sep 2027, 58 months after the start.

Of 54 non-industry interventional studies with no phase under Post-Concussion Syndrome, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 58. This study's planned 58 months is above that.

Counting every sponsor, half of 56 studies reached it within 40 months; a quarter within 23 and three quarters within 69.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 20, 2023
First posted
Aug 29, 2023
StartActual
Nov 1, 2022
Primary completionEst.
Sep 1, 2027
CompletionEst.
Sep 1, 2028
Last update
Aug 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06015451
Lead sponsor
St. Olavs Hospital
Responsible party
Sponsor
First posted
Aug 29, 2023
Start date
Nov 1, 2022
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2028 (estimated)
Last update
Aug 11, 2026

Study contacts

Toril Skandsen, PhD
Contact
toril.skandsen@ntnu.no
+4792692780
Janne-Birgitte BB Børke, MSc
Contact
janne.borke@stolav.no
Britt-Elin Lurud, MD
study director · Clinic of Rehabilitation, St. Olavs Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion